DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity.
about
Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccinationDNA vaccines: a simple DNA sensing matter?Molecular mechanisms for enhanced DNA vaccine immunogenicity.AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.Innate Immune Signaling by, and Genetic Adjuvants for DNA VaccinationHarnessing DNA-induced immune responses for improving cancer vaccines.Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.DNA-dependent activator of interferon-regulatory factors (DAI) promotes lupus nephritis by activating the calcium pathway.Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditisExpression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunityCytosolic DNA Sensor Upregulation Accompanies DNA Electrotransfer in B16.F10 Melanoma CellsImmune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice.The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy.DNA vaccination against oncoantigens: A promise.Cytosolic sensing of aberrant DNA: arming STING on the endoplasmic reticulum.Pattern recognition receptors: immune targets to enhance cancer immunotherapy.NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses.New adjuvants in evolving vaccine strategies.Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.Vaccination-induced skin-resident memory CD8+ T cells mediate strong protection against cutaneous melanoma.
P2860
Q21131298-4757F66D-323C-434D-BB21-A445D64CEA7CQ26859016-B729BA2F-15EA-41B7-BB7F-40FA44D821A6Q30366743-4526DBC8-D0C1-4373-8CF0-F42F02A6B46CQ33774747-89DDE9AD-7C89-45FA-926B-67BDC2C31B45Q34506918-CACDC62E-BF93-4969-B6AD-1911681D0F90Q35826673-E3CA07DC-D5BE-4F2C-A857-59CDB695347AQ36694866-0BD54181-265C-4013-BDE3-25AD27ECD7DDQ36694876-61460DE4-C24C-41F5-9E6C-98B508B2EBC7Q36807121-F2AD83AF-F1E5-4172-AD72-2E55D9E7053EQ36832638-317AEC4D-E177-4993-A80C-A19344E9616DQ36977614-1912C74C-3B58-4990-A86E-718A59D91B5CQ37225198-AE20833B-76FF-4F9F-B248-FB470908D7E4Q37254630-F1EF032C-96F1-4C3E-A96E-89B3FD537F80Q37687530-DF2BB75B-263B-478F-8DC0-36CEE3A21407Q37729321-AE08150C-AA92-48E7-91AF-B3C7FEF749B6Q38022032-A0351FBC-113C-4904-AD6B-1C13A1CB4120Q38556467-5B99F1FD-4AC6-40CA-B170-8D2D9A964DD8Q38690773-C24ABA10-3368-4F81-83E1-497E999EF24BQ45723785-65EEF2F6-0713-4272-9D99-BFA39A782CB7Q51007398-7500A5C0-8CF5-4A55-941C-B83D4880B430Q52568331-128403E6-E078-47A9-B081-D4EB3B160793Q55122008-13865E50-5966-4EB1-A307-49D74660F288
P2860
DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
DAI (DLM-1/ZBP1) as a genetic ...... ective antitumor CTL immunity.
@en
DAI
@nl
type
label
DAI (DLM-1/ZBP1) as a genetic ...... ective antitumor CTL immunity.
@en
DAI
@nl
prefLabel
DAI (DLM-1/ZBP1) as a genetic ...... ective antitumor CTL immunity.
@en
DAI
@nl
P2093
P2860
P356
P1433
P1476
DAI (DLM-1/ZBP1) as a genetic ...... fective antitumor CTL immunity
@en
P2093
Alvaro Lladser
Andrew Fg Quest
Dimitrios Mougiakakos
Helena Tufvesson
Rolf Kiessling
P2860
P304
P356
10.1038/MT.2010.268
P577
2010-12-14T00:00:00Z